Endocyte, Inc.

After a strong start to biopharma merger-and-acquisition activity in the first quarter of 2024, transactions declined notably in the second quarter, according to data provided by Evaluate. The second

Looking to stay ahead of the competition in the fast-moving radiopharmaceutical space, Novartis AG agreed to pay $1bn up front on 2 May to acquire privately held Mariana Oncology , a deal the pharm

As the major introductory fundraise for start-ups, Series A financings represent the first-time companies raise substantial equity from venture investors. Prior to the Series A, new firms may raise fu

Novartis AG 's 177Lu-PSMA-617 has met both overall survival (OS) and radiographic progression-free survival (PFS) primary endpoints in the Phase III VISION study in prostate cancer, but the company is